Skip links

Novela in the News & Key Events

June 3
2020

CEOCFO Magazine covers Localization and Translation Services, Women's Health, COVID-19 Vaccines

CEOCFO interviews CEOs discussing Electronic Propulsion Motors, Sleep Apnea Treatment, Neuromodulation Therapy and Emergency Management Services

Read Full Article
June 2
2020

How a Crowdsourcing Challenge Turbocharged Brain Research During Lockdown

In mid-March, a trifecta of academic, non-profit, and commercial neurotech companies united to launch a neuroscientific challenge that embodied a more collaborative future for solving the brain, while physically apart and working from home.

Read Full Article
June 1
2020

Novela Neurotech Seeks to Accelerate Neurological Treatments with Brain Decoding as a Service

Novela Neurotech is a spin off from a Canadian university, the University of Waterloo. We have a long track record of university research and development in what we call the field of neuromodulation, which is basically a way to alter brain functions through different modalities, such as using electricity to change the way brain cells communicate.

Read Full Article
May 29
2020

“BIOMED IRREGULARS” WON THE FIRST PLACE IN NEUREKA CHALLENGE!!!

A researcher team from STADIUS: “Biomed Irregulars” won the first place in Neureka Challenge!!! Neureka challenge was a month-long challenge organized by Novela Neurotech and NeuroTechX on seizure prediction using the TUH EEG Seizure dataset (one of the biggest available seizure datasets).

Read Full Article
April 27
2020

Novela Neurotech Appoints Aiman Abdel-Malek, Ph.D., to Board of Directors

As a highly experienced business strategic visionary leader, Dr. Abdel-Malek will support Novela in discovering dynaceutical therapies for brain disorders.

Read Full Article
April 23
2020

Novela Neurotech joins INCF's Industry Advisory Council to advance open neuroscience

By partnering with INCF, one of the world’s largest institutions promoting data and software reuse and reproducibility in brain research, Novela positions itself as an industry leader in neuroscience data sharing and collaboration.

Read Full Article
April 15
2020

Novela Featured in San Francisco Business Times: An Island of Innovation

Alameda is known for many things—among them, the monthly antiques fair, the former Naval Air Station and the U.S.S. Hornet, spirits distilleries, a vintage pinball museum, and as the birthplace of popsicles and creamy peanut butter.

Read Full Article
April 1
2020

Online Neureka™ challenge launches to crowdsource EEG solutions for epilepsy

Novela Neurotech and NeuroTechX are teaming up in an effort to accelerate epilepsy research

Read Full Article
April 1
2020

Alameda Magazine [print], April, 2020: “Alameda’s Implant Pioneer” by Keith Gleason

Request Print Article
February 6
2020

CRANIA to host collaborative neuromodulation workshop with Novela Neurotech and Hahn-Schickard

CRANIA, Novela Neurotech and Hahn-Schickard unites to accelerate the translation of Novela’s open source neuromodulation research kit.

Read Full Article
February 4
2020

Novela Neurotech teams up with UCSF to break down neurodata borders

Novela Neurotech teams up with UCSF to break down neurodata borders. Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.

Read Full Article
January 14
2020

Novela Neurotech participates in the 38th J. P. Morgan Healthcare Conference 2020

San Francisco, CA — Novela Neurotech, a neurotechnology company developing next-generation neural prosthesis for epilepsy treatment, will showcase its prototype system at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2020.

Read Full Article
January 14
2020

Novela Neurotech showcases smart neural interface at Creative Destruction Lab

Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders.

Read Full Article
November 12
2019

Novela Neurotech begins testing wireless, read-write capable brain prosthesis

Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness.

Read Full Article
October 23
2019

A New Theory of Brain Organization takes aim at the Mystery of Consciousness

Novela Neurotech, a MedTech company developing AI-powered wireless, “smart” neural interface systems, joins Canada’s Creative Destruction Lab to further fine-tune its health technologies to the needs of patients with difficult neurological disorders.

Read Full Article
July
2019

Novela’s Neureka™ and the Future of Neurostimulation

“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.”

Read Full Article
January
2019

Novela Inaugurates R&D Center

Based in Ontario, Canada.

R&D Hub will facilitate collaboration with CRANIA and access to tier-1 talent in the Waterloo and Toronto areas.

January, we opened our research and development (R&D) center in Waterloo, Canada. Working in concert with the California headquarters, the center will focus on the advancement of the fabrication process of Novela’s neural implant devices.

January 24
2019

In The Press

Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.”

Read Full Article
December
2018

In The Spotlight

Mark Valentine, Senior VP, Business Development & IP Portfolio

“I’ve witnessed firsthand the need for medical devices and treatments in those regions less fortunate than the western world. I think that’s why I’m so attracted to medical devices and technology companies.”

Read Full Article
March
2018

Novela Neurotechnologies: Ushering in the Next-Generation of Personalized Neurological Care

The company develops biocompatible neural implants that monitor, recognize, and intervene in neurological disorders through personalized treatment protocols.

Read Full Article